From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%. Last year was a transformative year for the Indianapolis-based pharmaceutical giant ...

A daily GLP-1 pill can help people with type 2 diabetes regulate their blood sugar and lose weight, drugmaker Eli Lilly announced on Thursday. The readout comes just days after Pfizer announced it ...

Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes management results when compared to the pill’s injectable counterparts. About 1 in 8 adults in the U.S. has ...

Eli Lilly stock (NYSE: LLY) is gaining momentum on Thursday, April 17th, following the company’s announcement of successful results from the first of its late-stage trials for a daily obesity ...

Drug manufacturer Eli Lilly's weight loss pill has completed late-stage trials for people with type 2 diabetes. The pill could offer an alternative to injectables. 90-day clock expires on ...

I watched Eli Sharabi. An eyewitness to horror. A forced journey through hell. I have no right to claim understanding. How can anyone? Empathy is the only tool of the imagination to relate, but for ...

Drug maker Eli Lilly says data from a late-stage trial showed a reduction in weight of almost 8% in people with Type 2 diabetes. Donald Trump Pulls Obnoxious Stunt As Canada Elects Its Prime ...

Eli Lilly's Zepbound injection is available to patients for weight loss. Photo: Shelby Knowles/Bloomberg via Getty Images ...

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer ...

We recently published a list of Jim Cramer Reacts to the Surprise Market Surge and Highlights 8 Key Stocks In this article, we are going to take a look at where Eli Lilly and Company (NYSE ...